The IgG3 Subclass of β1-adrenergic receptor autoantibody is an endogenous biaser of β1AR signaling.

Dysregulation of immune responses has been linked to the generation of IgG autoantibodies that target human β1ARs and contribute to deleterious cardiac outcomes. Given the benefits of β-blockers ob...